Identifying SARS-CoV-2 Spike Protein that Elicits Neutralising Antibodies

Together with the local R&D ecosystem, our scientists identified immunogenic targets against the coronavirus spike glycoprotein to provide crucial advances towards the development of diagnostic tools and potential vaccine candidate targets.

Lisa Ng, SIgN
Laurent Rénia, ID Labs
Wang Cheng-I, SIgN

Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients   more
Nature Communications

Lisa Ng Antibodies against S14P5 and S21P2 copy
Antibodies against S14P5 and S21P2 linear B-cell epitopes neutralise SARS-CoV-2.